Asthma Drug Reduces Need for Medication
March 31, 2011
A study finds the drug Xolair greatly reduced seasonal asthma attacks and the need for controller medication in a group of inner-city children.
Topics:
Health Medical Pharma, Social Issues, Omalizumab, Monoclonal antibodies, asthma, seasonal asthma, controller, Talizumab
